Entries by Thomas Gabrielczyk

Life-sciences hub Saxony: a driver of innovation for cell and gene therapy

Saxony has established itself as a dynamic life-sciences hub and provides an attractive environment for investors and start-ups The ‘SaxoCell’ network and CMI major research centre are furthering innovations in cell and gene therapy Interdisciplinary co-operation offers huge growth opportunities for applications such as point-of-care diagnostics Leipzig as host of BIO-Europe 2022

mRNA for Africa

Moderna will build its first mRNA production facility in Kenya, investing up to US$500m.